뒤로
Icecure Medical Ltd(ICCM) 가격
ICCM 주가 차트
ICCM 수입
Icecure Medical Ltd
$0.59
7.03%
$0.03
종가: Feb 06, 16:00:00 GMT-5
$0.59
0%
$0
애프터마켓: Feb 06, 20:00:00 GMT-5
최신 수익 결과: Q3 '25
보고됨: 2025-11-19
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
ICCM의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Icecure Medical Ltd ICCM의 지난 분기 매출 실적은 어땠나요?
Icecure Medical Ltd의 매출 추정치는 얼마인가요?
Icecure Medical Ltd의 수익 품질 점수는 얼마인가요?
Icecure Medical Ltd는 언제 수익을 보고하나요?
Icecure Medical Ltd의 예상 수익은 얼마인가요?
Icecure Medical Ltd은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.5512
시가
$0.564
일일 범위
$0.564 - $0.6
52주 범위
$0.54 - $1.66
거래량
132.5K
평균 거래량
342.6K
EPS(TTM)
-0.26
배당수익률
--
시가총액
$40.6M
ICCM란 무엇인가요?
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. The firm operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.